Clinical trials
Observational Drug-Related Side Effects and Adverse Reactions trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 4 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Groupe Hospitalier Pitie-Salpetriere | 4 |
| Hospices Civils de Lyon | 4 |
| University Hospital, Caen | 3 |
| University Hospital, Montpellier | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| CHU de Reims | 1 |
| Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | 1 |
| European Georges Pompidou Hospital | 1 |
| Protherics Medicines Development Limited | 1 |
| University Hospital, Lille | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Drug-Related Side Effects and Adverse Reactions | 21 |
| Neoplasms | 3 |
| Emergencies | 2 |
| Heart Failure | 2 |
| Metabolic Diseases | 2 |
| Stroke | 2 |
| Acute Kidney Injury | 1 |
| Antiphospholipid Syndrome | 1 |
| Atrial Fibrillation | 1 |
| Brain Injuries | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.